Martin, Bronwen <br/><br/>
Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease.  [electronic resource] 

 -  Diabetes  Feb 2009 
 - 318-28 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1939-327X 
<br/><br/><label>Standard No.: </label>10.2337/db08-0799  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipokines--blood<br/>Animals<br/>Blood Glucose--drug effects<br/>Blotting, Western<br/>Brain--drug effects<br/>Disease Models, Animal<br/>Enzyme-Linked Immunosorbent Assay<br/>Exenatide<br/>Ghrelin--blood<br/>Huntington Disease--blood<br/>Immunohistochemistry<br/>Insulin--blood<br/>Male<br/>Mice<br/>Pancreas--drug effects<br/>Peptides--therapeutic use<br/>Radioimmunoassay<br/>Survival Rate<br/>Venoms--therapeutic use